Replies to post #144039 on Amarin Corp Plc (AMRN)

[another_investor_1]

I would agree. The fact is it has 5% share in current treated market(4%).

Imagine
1. If they increase 5% to 70%
2. If they get 30-40% of untreated 96%
3. If they triple the price

$10 b a year is doable.
Vascepa uniqueness will remain for longvtime as low dose epa with dha(increases ldl) will either fail cv or be inferior to vascepa

So $50 stock possible if they steward it properly